CIGNA Co. (NYSE:CI) EVP John M. Murabito sold 28,037 shares of the stock in a transaction that occurred on Wednesday, January 10th. The stock was sold at an average price of $205.68, for a total value of $5,766,650.16. Following the completion of the transaction, the executive vice president now owns 60,290 shares in the company, valued at approximately $12,400,447.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
CIGNA Co. (CI) traded up $2.50 during mid-day trading on Friday, hitting $213.39. The stock had a trading volume of 1,151,291 shares, compared to its average volume of 1,240,000. CIGNA Co. has a 52 week low of $133.52 and a 52 week high of $213.73. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $52,610.00, a price-to-earnings ratio of 23.37, a PEG ratio of 1.44 and a beta of 0.51.
CIGNA (NYSE:CI) last issued its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, topping the Zacks’ consensus estimate of $2.36 by $0.47. The business had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. CIGNA had a return on equity of 18.85% and a net margin of 5.74%. CIGNA’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period last year, the company posted $1.94 earnings per share. research analysts expect that CIGNA Co. will post 10.34 EPS for the current year.
CI has been the topic of several recent research reports. Jefferies Group increased their price target on CIGNA from $221.00 to $231.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. Zacks Investment Research lowered CIGNA from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Citigroup raised their target price on CIGNA from $198.00 to $231.00 and gave the company a “buy” rating in a report on Friday, November 3rd. ValuEngine upgraded CIGNA from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. Finally, BMO Capital Markets assumed coverage on CIGNA in a report on Monday, October 16th. They issued a “market perform” rating and a $210.00 target price on the stock. Three research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $205.18.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with our FREE daily email newsletter.